Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors

Psychopharmacology

Volumn 165, Issue 1, 2002, Pages 60-66

  Martínez Mota, Lucía ^a   Estrada Camarena, Erika ^a,b   López Rubalcava, Carolina ^b  

^a Inst Nac de Psiq R de la F M   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT1A receptors; 8 OH DPAT; Antidepressants; Buspirone; Forced swimming test; Indorenate

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; INDORENATE; KETANSERIN TARTRATE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

5-METHOXYTRYPTAMINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZAMIDES; BUSPIRONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; KETANSERIN; MALE; MOTOR ACTIVITY; PINDOLOL; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SWIMMING;

EID: 0036936306     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1222-z     Document Type: Article

References (51)

1. Appelberg BG, Syvalahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH (2001) Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: Results from a placebo-controlled, randomized, double-blind, placebo wash in study. J Clin Psychiatry 62:448-452
2. (1A) receptors induced by venlafaxine. Neuropsychopharmacology 23:294-306
3. Blier P (2001) Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry 62:12-17
4. Benítez-King G, Antón-Tay F, Hong E (1991) Characterization of indorenate effects on brain monoamine metabolism. Drug Dev Res 23:325-331
5. Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94:147-160
6. 1A receptors in augmenting antidepressant activity in the mouse forced swimming test. Psychopharmacology 136:226-234
7. Caccia S, Conti I, Vigano G, Garattini S (1983) 1-(2-pyrimidinyl)-piperazine as active metabolite of buspirone in human and rat. Pharmacology 33:46-51
8. Carli M, Prontera C, Samanin R (1989) Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br J Pharmacol 96:829-836
9. 1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 158:53-59
10. (1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: The mechanism of action of (±)pindolol. Neuropharmacology 39:1044-1052
11. Detke MJ, Rickels M, Lucki I (1995) Active behaviours in the rat forced swimming test differently produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121:66-72
12. Detke MJ, Johnson J, Lucki I (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5:107-112
13. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology 212:1-26
14. Dimitrou EC, Dimitrou CE (1998) Buspirone augmentation of antidepressant therapy. J Clin Psychopharmacol 18:465-469
15. 1 binding sites as target for a novel putative anxiolytic. Naunyn-Schmiedebergs Arch Pharmacol 328:467-470
16. 1A receptor in the anxiolytic action of indorenate and ipsapirone. Psychopharmacology 101:354-358
17. Fernández-Guasti A, Escalante A, Hong E, Agmo A (1990) Behavioral actions of the serotonergic anxiolytic indorenate. Pharmacol Biochem Behav 37:83-88
18. 1A-receptor ligands in dorsal raphe and ventral hippocampus. Pharmacol Biochem Behav 54:123-128
19. 1A receptor antagonist, WAY 100635. Eur J Pharmacol 281:81-88
20. Fuller RW, Perry KW (1989) Effects of buspirone and its metabolite, the 1-(2-pyrimidinyl)piperazine, on monoamines and their metabolites in rats. J Pharmacol Exp Ther 248:50-56
21. Golembiowska K, Wedzony K (1993) Enhancement by ipsapirone of dopamine release in the rat striatum. Pol J Pharmacol 45:299-308
22. Hong E (1981) A serotonergic antihipertensive agent. In: Singer TP, Ondarza R (eds) Molecular Basis of Drug Action. Elsevier, Amsterdam, pp 247-252
23. Hjorth S, Carlsson A (1982) Buspirone: Effects of central mono-aminergic transmission - Possible relevance to animal experimental and clinical findings. Eur J Pharmacol 83:299-303
24. 3H]-ketanserin. Eur J Pharmacol 118:3-23
25. 1A receptor agonists on operant responding under a response duration of differentiation schedule. Behav Pharmacol 9:309-318
26. (2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioural observation studies in rats. J Pharmacol Exp Ther 282:747-759
27. 1A receptor agonists in animal models of depression and anxiety. Pharmacol Toxicol 71:24-30
28. 1B antagonists by chemical modulation of 3-[3-(n,N-dimethy-lamino)propyl]-4-hydroxy-N-[4-(pyridin-4-yl) phenyl]benzamide (GR55562). J Med Chem 40:3542-3550
29. 1A receptors. Eur J Neurosci 12:3265-3275
30. 1B receptors in rats in the forced swimming test (FST). Naunyn's-Schmiedebergs Arch Pharmacol 358:R108
31. López-Rubalcava C, Lucki I (2000) Strain diferences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22:191-199
32. 1A compounds. Dev Psychobiol 29:157-169
33. Marangell LB (2000) Augmentation of standard depression therapy. Clin Ther 22:A39-A41
34. 1A agonist in the learned helplessness paradigm in rats. Psychopharmacology 104:275-278
35. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999) Serotonergic mediation of the effects of fluoxetine but not desipramine, in the rat forced swimming test. Psychopharmacology 147:162-167
36. Pérez-Alvarez V, Morales-Ríos M, Hong E, Joseph-Nathan P (1997) Synthesis of 3-amino-2-(3-indolyl)propanol and propanoate derivatives and preliminar cardiovascular evaluation in rats. J Pharm Pharmacol 49:246-252
37. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730-732
38. Porsolt RD, Blavet AG, Jalfre M (1978) Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391
39. Rabin RA, Winter JC (1993) Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin. Eur J Pharmacol 235:237-243
40. Redrobe JP, Bourin M (1998) Dose-dependent influence of buspirone on the activities of selective reuptake inhibitors in the mouse forced swimming test. Psychopharmacology 138:198-206
41. 1B receptors in the antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol 318:213-220
42. (1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br J Pharmacol 129:1028-1034
43. 2C agonist: A study in rats. J Psychopharmacol 15:29-36
44. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol 95:975-985
45. 1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 4:625-636
46. 1A receptors. Neuropharmacology 32:331-340
47. Stahl SM (1998) Basic pharmacology of antidepressants, Part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59:15-24
48. Stahl SM (2000) Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. Cambridge University Press, Cambridge, pp 199-244
49. Velázquez-Martínez DN, Valencia-Flores M, López-Cabrera M, Villarreal JE (1995) Effects of indorenate on food intake: A comparison with fenfluramine and amphetamine. Psychopharmacology 117:91-101
50. Velázquez-Martínez DN, López-Cabrera M, Ramírez JI, Hong E (1999) Discriminative stimulus properties of indorenate, a serotonin agonist. J Psychiatry Neurosci 24:122-130
51. 1D subtypes. Br J Pharmacol 124:101-111